PreviousEntry : {9061B21B-61D2-43C7-B61E-AD2E3A7470B2} | Display Title : AccelTRA® RTS/RTU Components to Meet Premium Domestic Market Needs
NextEntry : {E5AF9CA5-F39A-45C0-BDB9-AA47ADFF6272} | Display Title : Is home-based administration possible? Exploring the intravenous to subcutaneous transition in cancer treatments.
来源
1. Based on IMS Analytics Link volume forecast (aggregated) from biologic molecules with marketed biosimilars or molecules expected to lose market exclusivity over the forecast period
Previous Next
Abigail Hisler

Abbey Hisler

Director, Strategic Marketing, Biologics

Click here to receive updates on the latest posts on the WestPharma blog
X
Reject